|
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News Archive - June 2022
Research Reveals Structure of a Human Endogenous Reverse Transcriptase
June 30, 2022 - The study, published in The Proceedings of the National Academy of Sciences (PNAS), describes the first-ever high-resolution three-dimensional structure of an endogenous reverse transcriptase – specifically human endogenous retrovirus-K (HERV-K) reverse transcriptase (RT). Past research has found a significant portion of the human genome is made up of repetitive elements that are relics of past viral infections, which are associated with a range of serious diseases, including cancer.
Study shows HIV speeds up body’s aging processes soon after infection
June 30, 2022 - Enrique Rivero - Changes at the DNA level can accelerate aging by nearly five years, UCLA-led research demonstrates
HIV has an “early and substantial” impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection, according to a study by UCLA researchers and colleagues.
The findings suggest that new HIV infection may rapidly cut nearly five years off an individual’s life span relative to an uninfected person.
Sharp rise in syphilis cases draws concern
June 29. 2022 - Health officials say STD testing, prompt treatment can prevent spread
Syphilis cases rose sharply in Minnesota in 2021, bringing them to concerning levels, according to an annual report of sexually transmitted diseases and HIV data from the Minnesota Department of Health.
'Real-world' study finds PrEP may be stopping 60% of HIV infections in French men at high risk of HIV
29 June 2022 - Gus Cairns - Study finds women gain more weight; underlines need to watch out for weight-related diseases
A study in France that matched new HIV diagnoses in adult men who had been taking PrEP with diagnoses in men at similar risk who had not been taking it, has found that the overall effectiveness of PrEP in stopping infection in this high-risk population was 60%.
Read more...
In Brief: Treating Precancerous Anal Lesions Reduces Anal Cancer Risk by More Than Half in People with HIV
JUNE 29, 2022 - A large clinical trial among people living with HIV has found that treating anal precancerous lesions cuts the risk of developing anal cancer by 57 percent compared with active monitoring with no treatment.
The ANCHOR study, published June 16 in the New England Journal of Medicine, was conducted at 25 clinical trial sites across the United States, including the Cornell HIV Clinical Trials Unit in the Division of Infectious Diseases at Weill Cornell Medicine, in collaboration with the institution’s Sandra and Edward Meyer Cancer Center. The findings highlight the need for screening and treating the lesion, called high-grade squamous intraepithelial lesions (HSIL), to become the standard of care for people 35 years or older who are living with HIV.
Weill Cornell Medicine Receives Cancer Grand Challenges Award Focused on Cachexia
JUNE 29, 2022 - Weill Cornell Medicine, Rutgers Cancer Institute of New Jersey and Cold Spring Harbor Laboratory have received a $25 million Cancer Grand Challenges award to tackle cancer cachexia, the debilitating wasting syndrome that is responsible for up to 30 percent of cancer-related deaths.
Cardiac Abnormalities of People Living with HIV: A Comparative Study Between HAART Experience and Treatment Naïve Groups in Ghana
June 29, 2022 - This study determined electrocardiographic and echocardiographic abnormalities of people living with HIV (PLWHIV); comparing the findings of PLWHIV on HAART versus treatment naïve groups.
Trial of potential universal flu vaccine opens at NIH Clinical Center
June 28, 2022 - A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The placebo-controlled trial will test the safety of a candidate vaccine, BPL-1357, and its ability to prompt immune responses. The vaccine candidate was developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID). The single-site trial can enroll up to 100 people aged 18 to 55 years and is led by NIAID investigator Matthew J. Memoli, M.D.
HHS Announces Enhanced Strategy to Vaccinate and Protect At-Risk Individuals from the Current Monkeypox Outbreak
June 28, 2022 - The U.S. Department of Health and Human Services (HHS) today announced an enhanced nationwide vaccination strategy to mitigate the spread of monkeypox. The strategy will vaccinate and protect those at-risk of monkeypox, prioritize vaccines for areas with the highest numbers of cases, and provide guidance to state, territorial, tribal, and local health officials to aide their planning and response efforts.
FACT SHEET: Biden-Harris dministration’s Monkeypox Outbreak Response
June 28, 2022 - Today, the Biden-Harris Administration announced the first phase of its national monkeypox vaccine strategy, a critical part of its monkeypox outbreak response. The vaccine strategy will help immediately address the spread of the virus by providing vaccines across the country to individuals at high risk. This phase of the strategy aims to rapidly deploy vaccines in the most affected communities and mitigate the spread of the disease.
Sask. researcher links high HIV rates to social assistance issues
June 28, 2022 - David Shield - U of S researcher says 2 infants born with HIV in province this year
A researcher at the University of Saskatchewan says low social assistance rates are contributing to the spread of HIV across the province.
Read more...
Feds Enhance Strategy to Vaccinate At-Risk People Against Monkeypox
June 28, 2022 - By Marie Rosenthal, MS - Given the difficulty in identifying the large number of contacts during the current monkeypox outbreak, the U.S. Department of Health and Human Services (HHS) announced that a vaccine will be provided to people with confirmed and presumed monkeypox exposures.
ECDC publishes contact tracing guidance for the current monkeypox outbreak
28 June 2022 - Cases of monkeypox have been continuously reported across the European region since the initial reports on 16 May. Due to this ongoing transmission, and following guidance published for event organisers and people at risk, the European Centre for Disease Prevention and Control (ECDC) has today published Considerations for contact tracing during the monkeypox outbreak in Europe, 2022.
Epidemiological experience and mathematical modelling have repeatedly shown case identification and contact tracing as important interventions in this current outbreak besides risk communication and community engagement. In this regard, the technical report provides advice and considerations to public health authorities in EU/EEA countries that are conducting contact tracing.
Gilead Resubmits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting HIV-1 Capsid Inhibitor
June 27, 2022 - FOSTER CITY, Calif.-- (BUSINESS WIRE )-- – NDA Resubmission Addresses Issues Related to Vial Compatibility –
– If Approved, Lenacapavir Would be the First and the Only HIV-1 Treatment Option Administered Twice-Yearly –
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the resubmission of the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lenacapavir, an investigational, long-acting HIV-1 capsid inhibitor, for the treatment of HIV-1 infection in heavily treatment-experienced (HTE) people with multi-drug resistant (MDR) HIV-1 infection.
HIV.gov FYI- Pride Month, National HIV Testing Day, and HIV Long-Term Survivors Awareness Day
June 27, 2022 - Listen to Harold Phillips, Director of the White House Office of National AIDS Policy discuss the importance of three observances, Pride Month, National HIV Testing Day, and HIV Long-Term Survivors Awareness Day.
Boot Camp for the Immune System
27-Jun-2022 - Newswise - Researchers discover new way in which T cells learn to tell friend from foe
The human immune system is a nearly perfect defense mechanism. It protects the body from disease-causing bacteria, viruses, and other pathogens. It detects nascent tumors and eradicates them. It cleans up cellular debris at the site of injury or infection.
To perform its myriad functions, the immune system must, above all, differentiate between self and non-self—a remarkable selective ability that allows it to detect and disable harmful agents while sparing the body’s own tissues.
Provincial HIV Testing Day Proclaimed In Saskatchewan
June 27, 2022 - Know Your HIV Status
Saskatchewan has proclaimed June 27 as the Provincial Human Immunodeficiency Virus Testing Day, which coincides with the annual National HIV Testing Day in Canada and the United States.
Aids: The Unheard Tapes, review: voices from beyond the grave bring the devastation to life
June 27, 2022 - By Anita Singh - BBC Two's excellent, heartbreaking documentary series vividly recreates both the era and the tragedy that came with it
Monday was national HIV testing day. Officials say this year's theme surrounds how getting tested is an act of self-care.
Read more...
Northern agencies highlight national HIV testing day
June 27, 2022 - Monday was national HIV testing day. Officials say this year's theme surrounds how getting tested is an act of self-care.
Read more...
The right to abortion is a critical link to HIV services and must be protected
26 June 2022 (Geneva, Switzerland) - On Friday, the US Supreme Court issued a ruling overturning federal protections for abortion rights and allowing states to impose severe restrictions on reproductive healthcare access across the country.
"For many individuals and families, reproductive healthcare is the first point of entry to the formal health care system and a critical link to HIV prevention, testing and treatment," Adeeba Kamarulzaman, President of IAS – the International AIDS Society – said. "The impact of the US Supreme Court’s ruling on abortion rights will be felt around the world."
How tennis legend Arthur Ashe became one of the most vocal HIV/AIDS activists
June 24, 2022 - By Leah Asmelash, CNN - Ashe became one of the most famous HIV-positive figures
Arthur Ashe may have been most known for his tennis success, but it was his activism that set him apart off the court.
Read more...
Looking for a definitive cure for HIV
June 24, 2022 - By Catarina Chagas -Infectious diseases clinician and researcher Santiago Perez is advancing work on HIV immunology and the ongoing search for a cure.
A lot has happened since the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) were first described in the early 1980s. Sexual health education campaigns have helped to curb transmission in most developed countries. Thanks to effective drugs, being infected no longer equals a death sentence. Yet, over 60,000 people in Canada and 37.7 million people worldwide still live with HIV and depend on medications daily, and for the rest of their lives. That's the only way to keep their viral loads low enough to avoid developing AIDS symptoms or transmitting the virus to others.
Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV
June 24, 2022 - FOSTER CITY, Calif.-- (BUSINESS WIRE )-- – If Authorized, Lenacapavir Could Offer a New, Every Six-Month Treatment Option for People with Limited Treatment Choices –
The CHMP positive opinion is a scientific recommendation to the European Commission (EC) to grant marketing authorization in Europe and will be reviewed by the EC, which has the authority to authorize medicines in the 27 Member States of the European Union, as well as Norway, Iceland and Liechtenstein. The final European Commission decision is expected later this year.
UNAIDS Board closes with significant decisions made on strengthening the global HIV response
GENEVA, 24 June 2022 - The 50th meeting of the UNAIDS Programme Coordinating Board (PCB) which began on 21 June has closed with decisions to strengthen access to HIV services for the people most vulnerable to the HIV pandemic and measures to help close the funding gaps in the global HIV response, including financing for UNAIDS.
High rate of new peripheral artery disease cases in people with HIV
24 June 2022 - Keith Alcorn - Study finds women gain more weight; underlines need to watch out for weight-related diseases
A study analysing data from four African countries found that people living with HIV who switched to a dolutegravir-based antiretroviral regimen had a four-fold increase in average weight gain, compared to the year before the switch.
Read more...
Enthusiastic response to monkeypox vaccination effort marred by supply concerns
June 23, 2022 -BySony Salzman - This week many had to line up for hours or be redirected to larger clinics, and there are concerns about demand outpacing supply, advocates said.
Hundreds of people from Toronto’s LGBTQ community have lined up in the past few days for a vaccine that offers protection against monkeypox, a virus spreading around the globe.
Newly diagnosed HIV cases dropped during the pandemic – here’s why that’s bad news
Jun 23, 2022 - Some of the groups most at risk had the sharpest declines in testing rates.
New HIV diagnoses dropped 17% during the first year of the pandemic, according to a new report from the Centers for Disease Control and Prevention, but researchers warn disruptions brought by the pandemic’s early lockdowns mean that far fewer people got tested.
Read more...
The Lancet Infectious Diseases:
COVID-19 vaccines are estimated to have prevented 20 million deaths worldwide in the first year of the vaccine programme, modelling study finds
June 23, 2022 - The Lancet - First modelling study to quantify the impact of COVID-19 vaccines on a global scale estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first year after vaccines were introduced (8 December 2020 - 8 December 2021).
COVID-19 vaccines reduced the potential global death toll during the pandemic by more than half in the year following their implementation, a mathematical modelling study published today in The Lancet Infectious Diseases estimates.
New Research Shows Mothers’ HIV Status, Breastfeeding, and the Infant Gut Microbiome Can Have Long-Term Impact on Infant Health
June 23, 2022 - Heide Aungst - The Research, Conducted by the UM School of Medicine, Could Lead to New Treatments
Babies born to women with HIV often have poorer health and under-developed growth in the early months of life than infants born to women without the infection — even if those babies don’t contract HIV during birth, according to a new study by researchers at the University of Maryland School of Medicine (UMSOM)’s Institute for Genome Sciences (IGS). The study also provides new insights into why these health issues often continue throughout the babies’ lives.
Jonathan Lax Memorial Award Lecture Streams Globally
PHILADELPHIA—(June 23, 2022) - World-wide reach of HIV cure initiative supports virtual event across countries.
The Wistar Institute, a biomedical research leader in cancer, immunology, and infectious disease, announces that for the first time it will globally stream its 26th Annual Jonathan Lax Memorial Award Lecture, celebrating 26 years of providing state-of-research updates to the community, on Tuesday, June 28 from 9:30 to 11:00 a.m. EST. From across the globe, scientists, activists, advocates, and community leaders will come together online to share scientific strides and community progress on the global HIV cure agenda front.
New treatment option shows promise in clearing HPV infection
June 22, 2022 - Daily use of a mushroom extract supported the immune system in clearing human papillomavirus (HPV) infections, according to researchers with UTHealth Houston. The study was published today in Frontiers in Oncology.
IMPROVING THE LIVES OF PEOPLE LIVING WITH HIV IN NORTH CAROLINA
22 June 2022 - Donte Prayer began volunteering in the HIV and sexual health sector over twenty years ago. Since 2019 he has been a Health Access Coordinator at North Carolina AIDS Action Network, a member of the Elton John AIDS Foundation’s partner Southern AIDS Coalition.
Charlize Theron, Sheryl Lee Ralph to Be Honored at Elizabeth Taylor Ball to End AIDS
Jun 22, 2022 - Charlize Theron and Sheryl Lee Ralph will receive the Elizabeth Taylor Commitment to End AIDS Award for their commitment to raising awareness of HIV at the Elizabeth Taylor Ball to End AIDS fundraising gala on Sept. 15 in West Hollywood Park in Los Angeles.
Read more...
Governments announce increased financial support to the global AIDS response
GENEVA, 22 June 2022 - Addressing the UNAIDS Programme Coordination Board, governments have begun to pledge new investments to advance the end of AIDS.
The United Kingdom and Germany were among those pledging increased resources to support the work of UNAIDS, the United Nations Joint Programme on HIV/AIDS.
Final barriers removed for Armed Forces personnel with HIV
21 June 2022 - Ministry of Defence - People with HIV, but no detectable virus, are now able to join the military and fully deploy on operations
From today, serving personnel who are taking suppressive treatment for HIV, and whose blood tests show no detectable virus, will now be recognised as fully fit for all service. The policy change also applies to anyone wishing to join the military, meaning living with HIV is no longer a barrier for those wishing to serve.
The Lancet Microbe: Typhoid-causing bacteria have become increasingly resistant to essential antibiotics and have spread widely over past 30 years
21st June 2022 - Largest genome sequencing study of S. Typhi – the bacteria that causes Typhoid fever – charts the emergence and spread of antibiotic-resistant strains.
Bacteria causing Typhoid fever are becoming increasingly resistant to some of the most important antibiotics for human health, according to a study published in The Lancet Microbe journal. The largest genome analysis of Salmonella enterica serovar Typhi (S. Typhi) also reveals that resistant strains – almost all originating in South Asia – have spread to other countries nearly 200 times since 1990.
People Living With HIV Have Markers of Accelerated Aging. Here’s How to Slow It Down
June 21, 2022 - Tim Murphy - In recent years, researchers have found that people with HIV—even those who are taking medications and are undetectable—age at a cellular level faster than people without HIV. The research was prompted by observations that people with HIV seemed to get many illnesses and conditions—such as heart disease, cognitive decline, and various cancers—sooner than people without HIV. (But it’s worth saying that so many other factors affect aging and age-related diseases, including diet, exercise, genes, smoking, drinking, and drug use.)
Read more...
Why the G7 Must Fully Fund the Fight Against HIV/AIDS, TB, and Malaria NOW
June 21, 2022 - COVID-19 has reversed progress on HIV/AIDS, TB, and malaria. Here’s what the G7 can do to help.
Due to COVID-19, progress on tackling HIV, tuberculosis (TB), and malaria has been reversed. In 2020, HIV testing fell by 22% and prevention services by 11%. TB deaths have increased for the first time in over a decade, fueled by a surge in the number of undiagnosed and untreated cases. Overall, the number of people being treated for TB fell by over 1 million. Malaria deaths and cases increased significantly, with new estimates suggesting a child is dying nearly every minute as a result of this mosquito-borne parasite.
Read more...
What it’s like to recover from monkeypox
June 21, 2022 - A Toronto resident shares his experience recovering from monkeypox, while officials and advocates say more support is needed for patients during the long weeks of isolation.
Watch Video...
Substantial weight gain as dolutegravir is rolled out in Africa
21 June 2022 - Shobha Shukla Bobby Ramakant - Study finds women gain more weight; underlines need to watch out for weight-related diseases
A study analysing data from four African countries found that people living with HIV who switched to a dolutegravir-based antiretroviral regimen had a four-fold increase in average weight gain, compared to the year before the switch.
Read more...
PEPFAR Stands with LGBTQI+ Individuals; Planned Programming for COP22 surpasses $235 million; New Partnership with UNDP to Counter Punitive and Discriminatory Laws
June 20, 2022 - As we honor Lesbian, Gay, Bisexual, Transgender, Queer, and Intersex (LGBTQI+) Pride Month, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) stands with members of the LGBTQI+ community and remains committed to providing person-centered treatment and services to those living with HIV globally.
TCF-1 Protein Plays Essential Role in Breaking Down Barriers as T Cells Form
PHILADELPHIA - June 20, 2022 -New understanding of protein function also has implications for immunotherapies
The protein TCF-1 enables various parts of otherwise insulated DNA segments to intermingle in a way that is required for the development of T cells—a key element of the body’s immune system—and the role this protein plays in T cell creation could shed new light on immunotherapy approaches, according to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania. The findings are published today in Nature Immunology.
AHF to Urge CDC, L.A. County Health Dept. to Revisit Condom Use
LOS ANGELES (June 19, 2022) - Reuters reports the World Health Organization (WHO) is now investigating reports that scientists have detected viral DNA in the semen of a handful of monkeypox patients in Italy and Germany; preliminary findings suggest the possibility, yet to be confirmed, that virus may also be sexually transmitted
AHF, the largest global AIDS organization with treatment clinics or operations in 45 countries, will host a Zoom Press Teleconference MONDAY, June 20 at 11:00 am PT (2:00 pm ET to discuss the recent global outbreak of monkeypox, which has disproportionately affected gay men or men who have sex with men.
Performance report demonstrates how the UN Joint Programme on HIV and AIDS has helped save lives
GENEVA, 18 June 2022 - This year’s UNAIDS performance report demonstrates how the UN Joint Programme on HIV and AIDS has critically contributed to key areas of the global HIV response and to saving lives, even in the face of the severe challenges and disruptions caused by the COVID-19 pandemic and financial shortfalls impacting the global HIV response and UNAIDS.
PrEP Stigma Still High Among Men Who Have Sex With Men
Newswise — June 17, 2022 - Joint education for male couples might expand the use of medication for preventing HIV
Many male couples in the U.S. seem to be underestimating the effectiveness of HIV pre-exposure prophylaxis (PrEP) for HIV prevention, and educating partners together could improve the number of male couples who decide to adopt PrEP. These conclusions come from a study reported in the July/August issue of The Journal of the Association of Nurses in AIDS Care (JANAC), the official journal of the Association of Nurses in AIDS Care. JANAC is published in the Lippincott portfolio by Wolters Kluwer.
Montreal AIDS conference organizer warns of 'catastrophe' if delegates denied visas
June 17, 2022 - Jacob Serebrin, Mia Rabson - The Canadian Press -
Hundreds of delegates from Asia, Africa and Latin America scheduled to attend a major AIDS conference in Montreal next month are in limbo because Ottawa has not issued them visas, organizers say, while dozens of others have seen their applications rejected.
Those who have either been denied visas or have not received a response from the Canadian government include researchers scheduled to present their work and delegates who received scholarships to attend the conference.
Read more...
What is the link between HIV and candidiasis?
June 17, 2022 - by Jenna Fletcher - Living with HIV can increase a person’s chances of developing candidiasis, which is an infection that occurs due to an overgrowth of the Candida fungus.
The Candida fungus typically lives on the body without causing any problems. However, if it grows out of control, it can lead to candidiasis.
Although anyone can develop candidiasis, people living with HIV have a higher chance of developing this type of infection.
Read more...
The Lancet: Disparities in life expectancy persist among racial and ethnic groups across the USA
16th June 2022 - The Lancet - New study offers the first comprehensive, county-level life expectancy estimates in the USA and highlights important differences among racial and ethnic groups.
Overall life expectancy in the USA increased by 2.3 years from 76.8 years in 2000 to 79.1 years in 2019, but disparities among the racial and ethnic groups remain widespread and persistent, according to a new study published in The Lancet. The study marks the first county-level analysis of life expectancy in the USA over an extended time period that includes estimates for the American Indian/Alaska Native (AIAN) and Asian/Pacific Islander (API) populations as well as Black, Latino, and White populations.
SUPERCOMPUTING HELPS REVEAL WEAKNESSES IN HIV-1 'ARMOR'
June 16, 2022 - by Jorge Salazar - TACC's Frontera system helps reveal the most realistic simulation study of HIV capsid to date
Much remains to be discovered on how the HIV-1 virus infects our cells. Scientists know that it slips past the defenses of our immune system, entering white blood cells to deliver its genetic payload and hijack the cell's transcription machinery that in turn cranks out copies of viral RNA and new HIV-1 viruses. But many of the details remain hazy.
State Department of Health Highlights HIV Home Test Giveaway In Honor of Pride Month
ALBANY, N.Y. (June 16, 2022) - Qualify for a HIV Home Test Here, To Learn Your HIV Status Without Sending a Sample to Lab or Visiting a Provider
Approximately 31% of Those Who Received a Free HIV Home Test Had Never Before Been Tested
In honor of Pride Month this June, the New York State Department of Health's AIDS Institute is highlighting the importance of HIV home testing as a tool to empower individuals to take control of their sexual health and mitigate the spread of HIV. To make HIV testing easier, the Department launched its seventh HIV Home Test Giveaway, which runs statewide outside of New York City, from May 2 through June 19.
HHS Awards $115 Million to Support Ending the HIV Epidemic in the United States
June 16, 2022 - Today, the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), awarded nearly $115 million to 60 recipients to help implement the Ending the HIV Epidemic in the U.S. (EHE) initiative, which is part of the Biden-Harris Administration’s ongoing efforts to reduce the number of new HIV infections in the United States by at least 90 percent by 2030. Awards will support innovative strategies that help people with HIV access care, support, and treatment services to live longer, healthier lives.
Community Organizations Calling for Emergency Supports and Services for Monkeypox
VANCOUVER, BRITISH COLUMBIA – June 16, 2021 - On June 6, the Community-Based Research Centre (CBRC) ? with the support of 47 other community organizations ? sent a letter to Minister of Health Jean-Yves Duclos, requesting a meeting and calling for the immediate creation of emergency financial and housing supports and wrap-around services for people with confirmed or suspected monkeypox infection. As of today, CBRC has yet to receive a formal response from the Minister of Health.
UNAIDS reports on the steps taken in building a safe, equal and empowering workplace
GENEVA, 16 June 2022 - In advance of the meeting of the UNAIDS Programme Coordinating Board taking place 21-24 June, UNAIDS is reporting publicly on the steps taken to date to strengthen accountability, counter harassment and build a safe, equal and empowering workplace.
Canada’s response to HIV is stuck in the past.
June 16 2022 - Stop the HIV Funding Freeze
HIV infections are increasing despite the availability of highly effective testing, treatment and prevention tools.
Since federal funding was frozen in 2008, the number of people living with HIV has increased 25%.
La réponse du Canada au VIH est figée dans le passé.
June 16 2022 - Mettez fin au gel du financement à la lutte au VIH.
Les infections au VIH augmentent malgré l’accessibilité à des outils de dépistage, de traitement et de prévention très efficaces. Depuis le gel du financement fédéral en 2008, le nombre de personnes vivant
avec le VIH a augmenté de 25 %.
 
Walgreens and Greater Than AIDS Partner with Health Departments and Community Organizations to Provide Free HIV Testing and Information in More Than 250 Cities on National HIV Testing Day (June 27)
DEERFIELD, Ill. & SAN FRANCISCO, June 15, 2022 - Largest Coordinated HIV Testing Event in the Nation
Walgreens and Greater Than AIDS, a public information initiative of KFF (Kaiser Family Foundation), are teaming up with health departments and community organizations in more than 250 cities to host the largest coordinated National HIV Testing Day (NHTD) event in the nation. Click here for a list of participating Walgreens stores and hours to get a free HIV test on Monday, June 27.
Hunter Reynolds, Pioneering Artist Known for Heart-Wrenching Works That Chronicled the Immense Loss Wrought by HIV/AIDS, Dies at 62
June 15, 2022 - BY MAXIMILÍANO DURÓN - Hunter Reynolds, an artist and activist whose expansive work influenced generations and poignantly reflected on the immense loss wrought by the AIDS crisis and took on that era’s homophobia, died on June 12 at his home in New York’s East Village. He was 62.
Read more...
New Terry Higgins portrait unveiled as Welsh Government outlines HIV action plan
15 June 2022 - The artwork of Terry from his school days was painted in Welsh colours of red and green by artist Nathan Wyburn.
A new portrait of a previously unseen childhood photo of Terry Higgins has been unveiled in the Senedd to mark 40 years since the Welshman became the first named person in the UK to die of an AIDS-related illness.
The unveiling, held on Wednesday 15 June, was part of an event held by the Welsh Government marking the past, present and future of HIV in Wales as it set out what it plans to do to end new HIV cases in the country. The event also marks the opening of a 12-week public consultation on its proposals.
Dolly Parton gives $1M to infectious disease research, again
NASHVILLE, Tenn. (AP) - June 15, 2022 - Dolly Parton is donating $1 million to pediatric infectious disease research at Vanderbilt University Medical Center in Nashville, the organization announced on Wednesday.
Read more...
Monitoring of responses to the hepatitis B and C epidemics in EU/EEA countries – 2020 data
June 15, 2022 - ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.
Nineteen European Union/European Economic Area (EU/EEA) countries have an action plan or a strategy for viral hepatitis prevention and control, according to a monitoring survey conducted by ECDC. Of these 19 countries, 11 reported that there was national funding for implementation.
In people with HIV, treating precancerous anal lesions cuts risk of anal cancer by more than half
June 15, 2022 - A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL, reduces the chance that anal cancer will develop by more than half.
Results from the Anal Cancer/HSIL Outcomes Research (ANCHOR) study were published June 16 in the New England Journal of Medicine. The trial was funded by the National Cancer Institute (NCI), part of the National Institutes of Health.
HIV treatments have progressed, but has the stigma?
June 14, 2022 - In recent years, medical advances have meant that living with HIV is no longer a death sentence, but HIV positive people say discrimination still exists.
LISTEN...
Groundbreaking treatment for HIV/AIDS developed by Israeli research team
June 13, 2022 - By SHIRA SILKOFF - The technology is based on a bacterial immune system against viruses, with the bacteria using the CRISPR systems as a molecular search engine, locating viral sequences and disabling them.
People with AIDS might soon have the option to be treated with just a single vaccine dose, according to a new study from Tel Aviv University that shows the potential impact of a new and unique AIDS/HIV treatment.
Read more...
35 Years since its first panels were stitched, The AIDS Memorial Quilt remains a powerful teaching tool for health action, remembrance and social justice
June 14, 2021: Thousands see largest Quilt display in a decade with 3,000 panels made during the darkest days of the pandemic and in recent years, a reminder that the fight for a cure, health and social justice is not over. National AIDS Memorial announces $2.4 million grant from Gilead Sciences to launch the Quilt Southern Initiative for new Quilt programming to tackle rising HIV rates within communities of color.
It has been 35 years since the first panels of the AIDS Memorial Quilt were stitched together, sparking a national movement for action, justice and remembrance for an epidemic that has claimed over 36 million lives around the world.
Breakthrough Technology Could Lead to One-Time HIV Treatment
June 14, 2021: TAU researchers demonstrate initial success in neutralizing the virus with a single vaccine
Researchers from Tel Aviv University demonstrated success of a novel technology that may be developed into a one-time vaccine to treat people with HIV and AIDS. The team used CRISP systems, best known as a gene-editing technique, to engineer type B white blood cells that activate the immune system to produce HIV-neutralizing antibodies.
ECDC and WHO publish joint technical report on navigating monkeypox during the summer season
June 14, 2021: As monkeypox cases rise, the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) have today published a technical report to provide advice for health authorities and event organisers for the upcoming summer.
With more than 700 monkeypox cases identified across Europe, and many public events attracting large numbers of citizens from across the continent, the report Joint ECDC-WHO considerations for public health authorities: navigating monkeypox during the Summer Season shows how public health authorities can focus on prevention messaging to promote good public health practices rather than closing venues.
Groundbreaking treatment for HIV/AIDS developed by Israeli research team
June 13, 2022 - By SHIRA SILKOFF - The technology is based on a bacterial immune system against viruses, with the bacteria using the CRISPR systems as a molecular search engine, locating viral sequences and disabling them.
People with AIDS might soon have the option to be treated with just a single vaccine dose, according to a new study from Tel Aviv University that shows the potential impact of a new and unique AIDS/HIV treatment.
Read more...
AIDS activist Allan Carpenter is still fighting to wipe out the stigma around the disease
June 12, 2022 - By Shinan Govani - The chef will cook for June’s HIV+ Eatery event in support of AIDS hospice Casey House
When the group of queer artists known as General Idea created their most recognizable work in 1987, they wanted to start a conversation about HIV/AIDS, which was already ravaging their community.
They made a deliberate attempt to spread the image like a virus, so it would be unavoidable for the population at large.
Read more...
Photos: AIDS Memorial Quilt 35th anniversary display in San Francisco’s Golden Gate Park
SAN FRANCISCO, CALIFORNIA - JUNE 12 - Jane Tyska and Jose Carlos Fajardo - The historic outdoor display of the AIDS Memorial Quilt came to the Robin Williams Meadow in San Francisco’s Golden Gate Park this weekend.
The 35th anniversary event was free to the public and featured more than 3,000 quilt panels. It’s the largest display of the Quilt in the U.S. in over a decade and the largest-ever AIDS quilt display in San Francisco history.
Read more...
World must ‘speed up’ efforts to end AIDS pandemic by 2030
GENEVA -June 11, 2022 - To end AIDS, beat COVID-19 and “stop the pandemics of the future”, the world needs to ensure global access to lifesaving health technologies, the UN Chef de Cabinet has told a meeting of the General Assembly to review progress.
The AIDS pandemic continues to be responsible for more than 13,000 deaths every week.
Read more...
Over 3,000 quilt panels displayed at SF's Golden Gate Park honoring those lost to AIDS
SAN FRANCISCO (KGO) - June 11, 2022 - Over 3,000 quilt panels were displayed in Golden Gate Park Saturday, with each representing a life lost to the AIDS pandemic.
Marking the 35th anniversary of the National Aids Memorial Quilts, activist, survivors and allies showed up to remember and honor lives affected by HIV.
Read more...
AIDS/LifeCycle Cyclists concluding a 7-Day journey from SF to LA June 11
WEST HOLLYWOOD - June 10, 2022 - By LA Blade Digital Staff - This year’s participants raised more than $17.8 million—the highest fundraising amount in the event’s history
The City of West Hollywood is a proud co-sponsor of AIDS/LifeCycle, an annual 7-day fundraising bicycle ride from San Francisco to Los Angeles benefitting the San Francisco AIDS Foundation and the Los Angeles LGBT Center.
Read more...
Hollywood mural remains beacon of hope in fight against HIV/AIDS
LOS ANGELES - June 10, 2022 - BY KRISTOPHER GEE - Restoring artists Russell Carlton’s 1987 Blue Moon Trilogy mural began in 2019. Now, Scott Haskins and his Fine Art Conservation Laboratories team have put the finishing touches on the final lower third of the mural which over the decades had been slowly disappearing.
Read more...
Barrie man becomes 'accidental activist' for living with HIV
June 10, 2022 - Nikki Cole - Randy Davis doing everything he can to 'smash the stigma' around HIV, and that includes taking part in the HIV+ Eatery event in Toronto
Randy Davis is a self-proclaimed “accidental activist."
The 55-year-old Barrie man gave himself that title about four years ago after deciding to publicly share his story about living with HIV.
Read more...
Historic Display: AIDS Memorial Quilt June 11th – 12th
June 10, 2022 - By: HIV.gov - The National AIDS Memorial will mark the 35th anniversary of the AIDS Memorial Quilt with a historic outdoor display on June 11th and 12th in San Francisco’s Golden Gate Park that will feature nearly 3,000 hand-stitched panels of the quilt.
HIV prevention: Uganda to benefit from vaginal ring rollout
Kampala, Uganda | THE INDEPENDENT | June 10, 2022 - Uganda has been selected among the initial beneficiaries of the International Partnerships for Microbicides (IPM), as the developers move to roll out the HIV-preventing vaginal ring in Africa.
The flexible vaginal ring which contains Dapivirine, an antiretroviral drug, is inserted in the vagina and left there for 28 days. During this time, the ring continuously releases antiretroviral drugs to prevent HIV infection.
Read more...
Exclusive: Anthony Fauci on the Aids crisis, monkeypox, trans rights and his retirement
June 9, 2022 - In an exclusive interview with Io Dodds, Dr Anthony Fauci looks back on his decades-long career in public health
The White House chief medical adviser, who has counselled every US president since Ronald Reagan and led the country’s national infection research institute since 1984, is speaking to The Independent about his experiences during the HIV/Aids pandemic in the Eighties – and the post-traumatic stress disorder that he still lives with today.
Read more...
THE LANCET HEALTHY LONGEVITY: Little evidence testosterone treatment increases the risk of cardiovascular events, most in-depth analysis suggests
8th June 2022 - Testosterone replacement therapy appears safe in the short-to-medium term to treat a condition caused by deficiency of the male sex hormone, according to the most comprehensive analysis of the treatment to date, published in The Lancet Healthy Longevity journal.
Queer collective General Idea’s AIDS project on display at the National Gallery
June 8, 2022 - By Nicole Thompson - When the group of queer artists known as General Idea created their most recognizable work in 1987, they wanted to start a conversation about HIV/AIDS, which was already ravaging their community.
They made a deliberate attempt to spread the image like a virus, so it would be unavoidable for the population at large.
Read more...
Next-Generation Viral Load Test Detects HIV at Lower Levels
June 8, 2022 - By Liz Highleyman - More people had a detectable viral load using a newer assay, which has implications for HIV treatment and prevention.
A new HIV viral load test can detect the virus at lower levels compared with older assays, meaning that some people who are “undetectable” according to older tests could still have a low level of the virus in their blood, according to a study published in the Journal of Antimicrobial Chemotherapy.
Read more...
Project to work with African and Caribbean heritage communities to reduce HIV stigma and infections
8 June 2022 - A major community-powered project in Bristol is set to launch an outreach programme to address HIV stigma and increase testing among people of African and Caribbean heritage.
Common Ambition Bristol brings together people of African and Caribbean heritage, working in equal partnership with healthcare professionals to develop new ways of increasing HIV awareness, encourage more people to get tested and tackle the stigma associated with HIV.
Dooley to lead Division of Infectious Diseases
Jun. 8, 2022 - Kelly Dooley, MD, PhD, MPH, has been appointed professor and Addison B. Scoville Jr. Chair in Medicine and director of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center, effective Sept. 12.
Augusta University’s Ryan White Program honored by Georgia Bio
JUNE 8, 2022 - Jennifer Hilliard Scott - A program aimed at addressing the unmet health needs of people living with HIV/AIDS was recently honored with a 2022 Golden Helix Award from Georgia Bio, the state’s life sciences advocacy and business leadership industry association.
The Augusta University Ryan White Program is a recipient of one of this year’s Community Awards, which are presented to a small number of individuals, companies or institutions whose contributions to Georgia’s life sciences community are worthy of special recognition.
Lambda Legal Celebrates Biden Administration’s Decision to Abandon Appeal of Court Order Striking Down Discriminatory Restrictions on Service Members Living with HIV and Welcomes Pentagon’s Policy Change
June 8, 2022 - Lambda Legal celebrates the Biden administration’s announcement yesterday that it will no longer defend discriminatory restrictions that prevented service members living with HIV from deploying and commissioning as officers in the U.S. military. Instead of appealing the decision of the district court declaring these restrictions unconstitutional, Defense Secretary Lloyd J. Austin III has issued a memorandum outlining changes to the relevant regulations and confirming that “[i]ndividuals who have been identified as HIV-positive, are asymptomatic, and who have clinically confirmed undetectable viral load will have no restrictions applied to their deployability or to their ability to commission while a Service member solely on the basis of their HIV-positive status.”
Emory participating in trial to test mRNA HIV vaccine in humans
June 7, 2022 - Emory News Center - Emory University is participating in a Phase I clinical trial to evaluate the use of messenger RNA (mRNA) technology in HIV vaccines for the first time in humans. The trial, IAVI G002, was launched earlier this year by IAVI, a nonprofit scientific research organization. Biotechnology company Moderna manufactured the vaccine candidate.
Department of Defense Updates Policy on HIV-Positive Service Members
JUNE 7, 2022 - U.S. Department of Defense - This week, the Secretary of Defense updated the Department’s policies on Human Immunodeficiency Virus-positive personnel serving within the Armed Forces in view of significant advances in the diagnosis, prevention, and treatment of HIV.
AIDS Vancouver
Announcing New Executive Director
Vancouver, BC - June 7, 2022 - Following a rigorous national search, the Board of Directors of AIDS Vancouver is pleased to announce the appointment of Sarah Chown to the position of Executive Director effective July 11, 2022.
Sarah brings a deep understanding of health equity and social justice, values central to AIDS Vancouver’s past, present and future. We’re excited about Sarah’s vision for an evolving, inclusive, anti-oppressive, transparent and values driven organization that strives to meet and exceed the ever-changing needs of the communities we serve.” – Michael Leclair, Board Chair
Antiviral gene known to block HIV also shows potent activity against SARS-CoV-2
June 7, 2022 - By ELLEN GOLDBAUM - New UB research reveals valuable information about the ways that host cells work to block entry of SARS-CoV-2 and, in turn, how the virus strikes back.
The findings uncover important features about cellular interactions between virus and host, and how they might be exploited to develop new methods of treatment for both SARS-CoV-2, the virus that causes COVID-19, and HIV.
HIV/AIDS: why we still need to ACT
7 June 2022 - James May - Opinion: finding a cure should be front and centre of our national response to HIV – but unfortunately it is not, writes James May, who has been living with the virus for over 20 years.
As someone living with HIV, I’m frustrated with the current discourse on HIV/AIDS in this country and abroad. Despite medical advances, around 40 million people are living with the virus globally, and around one million still die of AIDS each year.
Read more...
Quebec officials say 90 monkeypox cases have been detected in the province
June 7, 2022 - Quebec's Health Department says the province has a total of 90 confirmed cases of monkeypox.
That number is up from 71 confirmed cases reported last week.
Read more...
World’s largest HIV treatment programme could shift almost entirely to WHO-preferred first line regimen
7 June 2022 - Laura Lopez Gonzalez - The majority of South African HIV patients could be switched to the World Health Organization’s recommended first-line regimen if the country adopts advice from leading doctors. This would allow most people currently on the antiretroviral drug tenofovir to stay on that medication while adding dolutegravir and lamivudine to their HIV treatment regimen.
Read more...
Panels of national AIDS Memorial Quilt to be displayed at Marshall’s Carroll Gallery
JUNE 6, 2022 - Marshall University will present an exhibition featuring 10 blocks from the AIDS Memorial Quilt, a piece of art conceived in November of 1985 by longtime San Francisco gay rights activist Cleve Jones to create a memorial for those who had died of AIDS and help others understand the devastating impact of the disease.
Monkeypox Is Not a Gay Virus, the CDC Reminds Those Concerned
June 6, 2022 - Matt Grillo - The director of the Centers for Disease Control’s Division of HIV/AIDS Prevention clears up the misconceptions about the virus, but warns it's likely to spread.
Monkeypox is not a gay disease. It is not a gay virus. It is not a gay plague. It is not HIV 2.0.
Read more...
Monkeypox in Multiple Countries
June 6, 2022 - CDC - Cases of monkeypox have been reported in Europe, North America, South America, Africa, Asia, and Australia (see full list of countries below). Some cases were reported among men who have sex with men. Some cases were also reported in people who live in the same household as an infected person.
Monkeypox cases soar in UK, with more than 300 confirmed
Jun 06, 2022 - Stephanie Soucheray - CIDRAP News - Today, the UK Health Security Agency (UKHSA) said an additional 77 monkeypox cases have been confirmed across the United Kingdom, bringing the outbreak total to 302 as of yesterday. There are currently 287 confirmed cases in England, 10 in Scotland, 2 in Northern Ireland, and 3 in Wales.
HIV control approaches may not work for TB: lessons from South Africa and Zambia
June 6, 2022 - Helen Ayles - Tuberculosis (TB) is one of the most deadly infectious diseases. Around 9.9 million people around the world fell ill with the disease in 2020 and an estimated 1.5 million people died.
The advent of HIV in the 1980s unleashed large increases in TB, particularly in sub-Saharan Africa. In some countries, the number of people diagnosed with TB quadrupled every year. People with HIV are particularly susceptible to falling ill with TB.
Monkeypox Is Not a Gay Virus, the CDC Reminds Those Concerned
June 6, 2022 - Matt Grillo - As monkeypox cases rise, just over 500 Quebecers have been vaccinated against the virus, according to public health officials.
Read more...
Over 500 Quebecers vaccinated against monkeypox so far: health officials
June 6, 2022 - Matt Grillo - As monkeypox cases rise, just over 500 Quebecers have been vaccinated against the virus, according to public health officials.
Read more...
He Helped Cure the ‘London Patient’ of H.I.V. Then He Turned to Covid.
June 6, 2022 - By Gautham Nagesh - Ravindra Gupta, who led the efforts that resulted in the second case of a patient being cured of H.I.V., was drawn into pandemic research.
Read more...
A Pride Retrospective: When AIDS emerged, local TV news made a difference
SAN FRANCISCO (KPIX) - JUNE 05, 2022 - BY ALLEN MARTIN - In the early 1980s, Pride celebrations in the Bay Area were shrouded in sorrow and grief as a lethal virus spread silently within the gay community.
On June 5, 1981, the Centers for Disease Control published a first report of five gay men in Los Angeles -- all previously healthy -- who had been diagnosed with a rare pneumonia.
Read more...
Long-Term HIV Survivors Share Their Stories of Tragedy and Triumph
JUNE 05, 2022 - By Desirée Guerrero - In honor of HIV Long-Term Survivors Awareness Day, June 5, these folks share some of their personal journeys of living with HIV for decades.
Read more...
What is AIDS Survivor Syndrome by Let’s Kick ASS?
HIV Long-Term Survivors describe life in the aftermath of AIDS.
Monkeypox FAQ: How is it transmitted? Where did it come from? What are the symptoms? Does smallpox vaccine prevent it?
June 5, 2022 - With cases reported in a number of countries, human monkeypox infection is generating global interest and concern as an emerging infectious disease threat even in the midst of a slowly relenting COVID-19 pandemic.
On HIV Long-Term Survivor Day – 40 Years of Fighting Fiercely
June 5, 2022 - Ben Klein - Today is the annual commemoration of HIV Long-Term Survivors Awareness Day.
Today also marks the 40th anniversary of the US Centers for Disease Control and Prevention’s June 5, 1981 report of five cases of pneumocystis pneumonia among gay men in Los Angeles. In words that are haunting with the knowledge of what soon followed, the report noted that the existence of pneumocystis pneumonia in previously healthy individuals was “unusual.” This correlation suggested that “[t]he fact that these patients were all homosexuals suggests an association between some aspect of a homosexual lifestyle or disease acquired through sexual contact.”
Read more...
HIV surge a setback for Saskatchewan First Nations
June 5, 2022 - Zak Vescera - Saskatchewan First Nations were internationally recognized for containing and treating HIV. Then the pandemic delivered a massive setback.
Before the pandemic, Dr. Ibrahim Khan said First Nations in the province were recognized internationally for expanding testing, prevention and treatment programs to combat sky-high rates of HIV — more than twice the provincial average, which itself is the highest in the country.
Read more...
AHF Swiftly Brings Aid to Recife, Brazil
SãO PAULO, BRAZIL (June 4, 2022) - In the northeast state of Pernambuco, over 100 people have died due to torrential rains and flooding
AHF Brazil, which provides HIV/AIDS care in 25 clinics in the country—including 3 clinics in Pernambuco and 5 in Recife —is delivering humanitarian aid to help over 600 individuals and families
Nashville will recognize June 5 as HIV Long-Term Survivors Awareness Day
NASHVILLE, Tenn. (TN Tribune) - June 4, 2022 - On Friday, June 3, Mayor John Cooper and the Metro Public Health Department held a special signing ceremony of the Paris Declaration 4.0 that designates Nashville as a ‘Fast-Track City’ and joins dozens of cities across the world in an international movement to combat the HIV/AIDS virus.
Read more...
Preclinical Data on Novel Arenaviral HIV Therapeutic Vaccines Presented at Keystone Symposium
NEW YORK and VIENNA, Austria, June 03, 2022 (GLOBE NEWSWIRE) -- Alternating 2-vector therapy induces greater immune response than single-vector therapy in preclinical setting and translates into significant reduction of viral load
HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced preclinical data, in collaboration with Gilead Sciences, Inc., on arenaviral therapeutic vaccines that are being studied as a component of a potential functional curative regimen for human immunodeficiency virus (HIV). These data presented at the Keystone Symposium: Progress in Vaccine Development for Infectious Disease in Breckenridge, Colorado highlight robust and high-quality immune responses following administration of replicating arenaviral therapeutic vaccines.
Palm Springs resident takes on 545-mile bike ride to raise funds for HIV/AIDS
June 3, 2022 - Ema Sasic - Palm Springs resident Brett Klein decided to celebrate one last hurrah 22 years ago — in the form of a 545-mile bike ride.
Read more...
First probable case of monkeypox identified in SF resident
June 3, 2022 - SF.Gov - The risk to the general public is low, but having close, intimate contact with multiple people can put a person at risk if monkeypox is spreading in the community
The San Francisco Department of Public Health (SFDPH) announced today that following a recent uptick in cases globally and in the United States, the first probable case of monkeypox has been identified in an SF resident through testing at a California Department of Public Health laboratory. The risk to the general population from this virus is believed to be low as the known cause of spread is prolonged contact and bodily fluids. Having close physical contact, including sex, with multiple people can put a person at higher risk for monkeypox.
Mobilize to Thrive, Improving Quality of Life: Long-Term Survivors Day 2022
June 03, 2022 -By: HIV.gov - HIV Long-Term Survivors Awareness Day (HLTSAD) is celebrated each year on June 5th, the anniversary of the first official reporting of what became known as HIV in 1981. HLTSAD celebrates the resiliency of long-term survivors living with HIV and highlights their journeys and challenges.
Genetic data suggest multiple monkeypox outbreaks, CDC says
June 3, 2022 - New genetic sequencing data indicate there are at least two separate monkeypox outbreaks underway outside of Africa, the CDC said Friday.
Read more...
Manulife provides life insurance to HIV+ individuals as part of its drive to build an inclusive and equitable society
HONH KONG - June 2, 2022 - Manulife Hong Kong today announced the offering of individual life insurance coverage1 to customers who are diagnosed with Human Immunodeficiency Virus (HIV). This breakthrough in underwriting means HIV-positive customers in Hong Kong and Macau will be able to apply and be covered by life insurance with Manulife Hong Kong, ensuring financial security for their loved ones and families.
HIV Long-Term Survivors Awareness Day June 5, 2022
June 2022 - “Mobilize To Thrive: Prioritizing Quality Of Life” is the 2022 theme and call to action.Hashtags: #Mobilize2Thrive & #HLTSAD
HLTSAD is not a one-day event. We are carrying our campaign throughout June 2022. We are using Pride as an opportunity to raise awareness that leads to action.
The selection of June 5 for this annual observance coincides with the anniversary of the first official reporting of what became known as the AIDS epidemic on June 5, 1981. When the CDC [Centers for Disease Control and Prevention] first reported on five cases of a mysterious disease affecting young gay men. June 5, 1981 is considered the start of the AIDS pandemic.
New blood test can help doctors diagnose tuberculosis and monitor treatment
June 01, 2022 - Researchers at Tulane University School of Medicine have developed a new highly sensitive blood test for tuberculosis (TB) that screens for DNA fragments of the Mycobacterium tuberculosis bacteria that causes the deadly disease.
The test could give doctors a new tool to both quickly identify TB and then gauge whether drug treatments are effective by monitoring levels of DNA from the pathogen circulating through the bloodstream, according to a new study published in the journal The Lancet Microbe.
New study provides essential insights into infectious disease risk during spaceflight
June 1, 2022 - Researchers found microgravity analog culture profoundly affects microbial infection process in 3D human tissue models
Infectious microbes have evolved sophisticated means to invade host cells, outwit the body’s defenses and cause disease. While researchers have tried to puzzle out the complicated interactions between microorganisms and the host cells they infect, one facet of the disease process has often been overlooked – the physical forces that impact host-pathogen interactions and disease outcomes.
Combination anti-HIV antibody infusions suppress virus for prolonged period
June 1, 2022 - Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), according to a small study published today in the journal Nature. The findings suggest that combination bNAb therapy might offer a future alternative to daily ART for people living with HIV. The research was conducted by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, in collaboration with researchers at the NIH Clinical Center; the Maple Leaf Medical Clinic in Toronto; the Frederick National Laboratory for Cancer Research; Harvard Medical School, Boston; and The Rockefeller University, New York City.
IDSA and CDC Launch New Disease Detective Training for Infectious Diseases Physicians
June 1, 2022 - The Infectious Diseases Society of America in collaboration with the Centers for Disease Control and Prevention has selected 11 ID programs for the first Joint ID/CDC Epidemic Intelligence Service Fellowship. Each of the 11 programs will serve as options for the ID fellowship track for the joint IDSA and CDC training program. The selected programs have demonstrated strong relationships with nearby state and local health departments and an in-depth focus on public health.
New rapid test for syphilis can give patients immediate access to treatment, Alberta doctors say
June 1, 2022 - Julia Wong - CBC News - A clinical trial in Alberta found a third of those tested were positive for the STI
Doctors are optimistic that a rapid syphilis test could help curb the spread of an ongoing outbreak of the sexually transmitted infection in the Prairies, following a promising clinical trial in Alberta.
Read more...
| 
